Forearm Bone Mineral Density and Fracture Incidence in Postmenopausal Women with Osteoporosis

被引：0
|
作者：
Watts, Nelson B. [1 ]
Dore, Robin K. [2 ]
Baim, Sanford [3 ]
Hattersley, Gary [4 ]
Williamss, Greg [5 ]
Wang, Yamei [4 ]
Rozental, Tamara D. [6 ]
LeBoff, Meryl S. [7 ]
机构：
[1] Mercy Hlth Osteoporosis & Bone Hlth Serv, Cincinnati, OH USA
[2] Univ Calif Los Angeles, Los Angeles, CA USA
[3] Rush Med Coll, Chicago, IL 60612 USA
[4] Radius Hlth Inc, Waltham, MA USA
[5] Radius Hlth Inc, Clin Dev, Waltham, MA USA
[6] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[7] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2018年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2302
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Forearm bone mineral density and fracture incidence in postmenopausal women with osteoporosis: results from the ACTIVExtend phase 3 trial
    Watts, N. B.
    Dore, R. K.
    Baim, S.
    Mitlak, B.
    Hattersley, G.
    Wang, Y.
    Rozental, T. D.
    LeBoff, M. S.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2021, 32 (01) : 55 - 61
  • [2] Forearm Bone Mineral Density and Fracture Incidence in Postmenopausal Women with Osteoporosis: Results from the ACTIVExtend Phase 3 Trial
    Watts, Nelson B.
    Dore, Robin K.
    Baim, Sanford
    Hattersley, Gary
    Williams, Greg
    Wang, Yamei
    Rozental, Tamara D.
    Leboff, Meryl S.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2018, 33 : 292 - 292
  • [3] Forearm bone mineral density and fracture incidence in postmenopausal women with osteoporosis: results from the ACTIVExtend phase 3 trial
    N.B. Watts
    R.K. Dore
    S. Baim
    B. Mitlak
    G. Hattersley
    Y. Wang
    T.D. Rozental
    M.S. LeBoff
    [J]. Osteoporosis International, 2021, 32 : 55 - 61
  • [4] Abaloparatide effect on forearm bone mineral density and wrist fracture risk in postmenopausal women with osteoporosis
    N.B. Watts
    G. Hattersley
    L.A. Fitzpatrick
    Y. Wang
    G.C. Williams
    P.D. Miller
    F. Cosman
    [J]. Osteoporosis International, 2019, 30 : 1187 - 1194
  • [5] Abaloparatide effect on forearm bone mineral density and wrist fracture risk in postmenopausal women with osteoporosis
    Watts, N. B.
    Hattersley, G.
    Fitzpatrick, L. A.
    Wang, Y.
    Williams, G. C.
    Miller, P. D.
    Cosman, F.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2019, 30 (06) : 1187 - 1194
  • [6] EFFECT OFABALOPARATIDE ON BONE MINERAL DENSITY AND FRACTURE INCIDENCE IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS AND OSTEOARTHRITIS
    Lane, N. E.
    Mitlak, B.
    Weiss, R.
    Wang, Y.
    Valenzuela, G. J.
    Bilezikian, J. P.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2019, 30 : S165 - S165
  • [7] Effect of Abaloparatide on Fracture Incidence and Bone Mineral Density in Postmenopausal Women with Osteoporosis at Highest Risk for Fracture
    Clarke, Bart
    Kostenuik, Paul
    Wang, Yamei
    Tough-DeSapri, Kristi
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2021, 28 (12): : 1448 - 1448
  • [8] Correction to: Abaloparatide effect on forearm bone mineral density and wrist fracture risk in postmenopausal women with osteoporosis
    N. B. Watts
    G. Hattersley
    L. A. Fitzpatrick
    Y. Wang
    G. C. Williams
    P. D. Miller
    F. Cosman
    [J]. Osteoporosis International, 2020, 31 : 1603 - 1605
  • [9] Correction to: Abaloparatide effect on forearm bone mineral density and wrist fracture risk in postmenopausal women with osteoporosis
    N. B. Watts
    G. Hattersley
    L. A. Fitzpatrick
    Y. Wang
    G. C. Williams
    P. D. Miller
    F. Cosman
    [J]. Osteoporosis International, 2020, 31 : 1017 - 1018
  • [10] Abaloparatide Followed by Alendronate on Bone Mineral Density and Fracture Incidence in Postmenopausal Women with Osteoporosis and Osteoarthritis
    Lane, Nancy
    Weiss, Richard
    Mitlak, Bruce
    Wang, Yamei
    Valenzuela, Guillermo
    Deal, Chad
    [J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
12345